InsidersTradesSigma
Follow the KALBE FARMA Tbk, PT share price and the full directors' dealings record of the company, a publicly traded company based in Indonesia. Shares trade on the ID market, under the supervision of OJK / IDX. Market capitalisation: €36,651.6bn. The latest transaction was filed on 24 August 2026 (Purchase). Among the most active insiders: FERDINAND ARYANTO. All data is free.
Analysts rate KALBE FARMA Tbk, PT Strong Buy (bullish), based on 17 analysts. Average price target: IDR 1,175.29.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
2 of 2 declarations
KALBE FARMA Tbk, PT 是一家印度尼西亚制药公司，专门生产药品、营养产品和保健产品。该公司在印度尼西亚证券交易所 (XIDX) 上市。